110 related articles for article (PubMed ID: 8864824)
1. Induction of diabetes in NOD<-->C57BL/6 embryo aggregation chimeras by cyclophosphamide through preferential depletion of C57BL/6 lymphocytes.
Colucci F; Lejon K; Cilio CM; Bergqvist I; Matsunaga T; Holmberg D
J Autoimmun; 1996 Aug; 9(4):493-9. PubMed ID: 8864824
[TBL] [Abstract][Full Text] [Related]
2. Diabetes induction in C57BL/6 mice reconstituted with lymphocytes of nonobese diabetic <--> C57BL/6 mouse embryo aggregation chimeras.
Colucci F; Bergman ML; Lejon K; Holmberg D
Scand J Immunol; 1998 Dec; 48(6):571-6. PubMed ID: 9874490
[TBL] [Abstract][Full Text] [Related]
3. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
4. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
Mathieu C; Casteels K; Bouillon R; Waer M
J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
[TBL] [Abstract][Full Text] [Related]
5. The phenotype of lymphoid cells and thymic epithelium correlates with development of autoimmune insulitis in NOD in equilibrium with C57BL/6 allophenic chimeras.
Forsgren S; Dahl U; Söderström A; Holmberg D; Matsunaga T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9335-9. PubMed ID: 1924397
[TBL] [Abstract][Full Text] [Related]
6. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
7. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Elkin G; Prigozhina TB; Slavin S
Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
[TBL] [Abstract][Full Text] [Related]
9. Non-diabetogenic insulitis in NOD<-->B10.GD allophenic mice in spite of permissive class I MHC antigens.
Colucci F; Dahl U; O'Reilly L; Cooke A; Chandler P; Simpson E; Matsunaga T
Scand J Immunol; 1994 Dec; 40(6):659-64. PubMed ID: 7997856
[TBL] [Abstract][Full Text] [Related]
10. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
[TBL] [Abstract][Full Text] [Related]
11. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
12. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide.
Colucci F; Cilio CM; Lejon K; Gonçalves CP; Bergman ML; Holmberg D
J Autoimmun; 1996 Apr; 9(2):271-6. PubMed ID: 8738973
[TBL] [Abstract][Full Text] [Related]
14. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
15. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
[TBL] [Abstract][Full Text] [Related]
17. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T
Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
19. Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.
Hermitte L; Atlan-Gepner C; Payan MJ; Mehelleb M; Vialettes B
Diabete Metab; 1995 Oct; 21(4):261-8. PubMed ID: 8529761
[TBL] [Abstract][Full Text] [Related]
20. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
